DekaBank Deutsche Girozentrale’s Ligand Pharmaceuticals LGND Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio LGND Stock Details LGND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-11,185	Closed	-$859K	–	1255
2025 Q4	$859K	Hold	11,185	–	–	﹤0.01%	907
2025 Q3	$1.93M	Hold	11,185	–	–	﹤0.01%	755
2025 Q2	$1.27M	Hold	11,185	–	–	﹤0.01%	815
2025 Q1	$1.19M	Hold	11,185	–	–	﹤0.01%	817
2024 Q4	$1.21M	Hold	11,185	–	–	﹤0.01%	840
2024 Q3	$1.08M	Hold	11,185	–	–	﹤0.01%	870
2024 Q2	$923K	Hold	11,185	–	–	﹤0.01%	896
2024 Q1	$792K	Hold	11,185	–	–	﹤0.01%	921
2023 Q4	$797K	Hold	11,185	–	–	﹤0.01%	943
2023 Q3	$687K	Buy	11,185 +1,185	+12%	+$78K	﹤0.01%	944
2023 Q2	$726K	Hold	10,000	–	–	﹤0.01%	945
2023 Q1	$708K	Hold	10,000	–	–	﹤0.01%	947
2022 Q4	$670K	Sell	10,000 -6,030	-38%	-$392K	﹤0.01%	971
2022 Q3	$847K	Buy	16,030 +8,752	+120%	+$514K	﹤0.01%	914
2022 Q2	$395K	Hold	7,278	–	–	﹤0.01%	1063
2022 Q1	$527K	Buy	7,278 +642	+10%	+$46.6K	﹤0.01%	1052
2021 Q4	$669K	Buy	6,636 +160	+2%	+$14.8K	﹤0.01%	1033
2021 Q3	$563K	Hold	6,476	–	–	﹤0.01%	1023
2021 Q2	$539K	Hold	6,476	–	–	﹤0.01%	1057
2021 Q1	$598K	Hold	6,476	–	–	﹤0.01%	996
2020 Q4	$396K	Sell	6,476 -321	-5%	-$18.3K	﹤0.01%	1070
2020 Q3	$400K	Buy	+6,797	New	+$464K	﹤0.01%	967
2019 Q4	–	Sell	-12,968	Closed	-$801K	–	1180
2019 Q3	$801K	Sell	12,968 -13,770	-51%	-$865K	0.01%	710
2019 Q2	$1.9M	Buy	26,738 +11,766	+79%	+$867K	0.01%	637
2019 Q1	$2.41M	Buy	14,972 +1,603	+12%	+$121K	0.01%	563
2018 Q4	$1.14M	Sell	13,369 -1,603	-11%	-$171K	0.01%	649
2018 Q3	$2.41M	Sell	14,972 -385	-3%	-$58K	0.01%	575
2018 Q2	$1.99M	Hold	15,357	–	–	0.01%	585
2018 Q1	$1.55M	Sell	15,357 -304	-2%	-$30.1K	0.01%	614
2017 Q4	$1.25M	Hold	15,661	–	–	0.01%	642
2017 Q3	$1.25M	Hold	15,661	–	–	0.01%	650
2017 Q2	$1.19M	Hold	15,661	–	–	0.01%	648
2017 Q1	$1.03M	Sell	15,661 -1,251	-7%	-$82.3K	0.01%	614
2016 Q4	$1.07M	Buy	16,912 +1,283	+8%	+$81K	0.01%	527
2016 Q3	$995K	Hold	15,629	–	–	0.01%	543
2016 Q2	$1.18M	Buy	15,629 +400	+3%	+$29.7K	0.01%	531
2016 Q1	$997K	Sell	15,229 -961	-6%	-$58.4K	0.01%	546
2015 Q4	$1.09M	Buy	16,190 +320	+2%	+$19.8K	0.01%	557
2015 Q3	$848K	Buy	15,870 +561	+4%	+$34K	0.01%	574
2015 Q2	$964K	Buy	15,309 +561	+4%	+$30.6K	0.01%	575
2015 Q1	$709K	Sell	14,748 -3,125	-17%	-$120K	0.01%	635
2014 Q4	$582K	Sell	17,873 -1,603	-8%	-$52.1K	0.01%	659
2014 Q3	$571K	Buy	19,476 +480	+3%	+$15.9K	0.01%	629
2014 Q2	$738K	Sell	18,996 -400	-2%	-$16.2K	0.01%	540
2014 Q1	$814K	Buy	19,396 +801	+4%	+$33.4K	0.01%	507
2013 Q4	$623K	Buy	18,595 +481	+3%	+$15.7K	0.01%	518
2013 Q3	$489K	Buy	+18,114	New	+$510K	0.01%	551

Other funds holding LGND

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return

DekaBank Deutsche Girozentrale's LGND Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Ligand Pharmaceuticals (LGND) in Q1 2026, closing a stake of 11,185 shares — an estimated $859K sold.

DekaBank Deutsche Girozentrale first reported a position in LGND in Q3 2013 and held it in 47 quarters. The position peaked at $2.41M in Q1 2019. 357 funds tracked by Wall St. Rank hold LGND as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Ligand Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 11,185 Ligand Pharmaceuticals shares in Q1 2026, an estimated $859K.
DekaBank Deutsche Girozentrale first reported a position in Ligand Pharmaceuticals in Q3 2013 and held it in 47 quarters.
DekaBank Deutsche Girozentrale's Ligand Pharmaceuticals position peaked at $2.41M in Q1 2019.
357 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.